Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05QUL
|
|||
| Former ID |
DIB007557
|
|||
| Drug Name |
T89
|
|||
| Synonyms |
2-Propanone, 1-(5-nitro-2H-tetrazol-2-yl)-; 131394-19-9; 1-(5-nitro-1,2,3,4-tetraazol-2-yl)acetone; ZERO/000247; AC1LOTQU; ACMC-20mu2z; 2-acetonyl-5-nitrotetrazole; CTK0C0970; DTXSID40361521; MolPort-001-904-996; ZINC1084291; STK760073; SBB000169; AKOS000558886; MCULE-5436124308; 1-(5-nitrotetrazol-2-yl)propan-2-one; 2-(2-Oxopropyl)-5-nitro-2H-tetrazole; ST026974; ST023819; BAS 01313849; 1-(5-Nitro-tetrazol-2-yl)-propan-2-one; EU-0085349; 1-(5-nitro-2H-tetrazol-2-yl)propan-2-one; SR-01000523987; SR-01000523987-1
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Angina pectoris [ICD-11: BA40; ICD-9: 413] | Phase 3 | [1] | |
| Multiple myeloma [ICD-11: 2A83; ICD-10: C90; ICD-9: 203] | Phase 3 | [2] | ||
| Structure |
 |
Download2D MOL |
||
| Formula |
C4H5N5O3
|
|||
| Canonical SMILES |
CC(=O)CN1N=C(N=N1)[N+](=O)[O-]
|
|||
| InChI |
1S/C4H5N5O3/c1-3(10)2-8-6-4(5-7-8)9(11)12/h2H2,1H3
|
|||
| InChIKey |
RNOFFEQSFLGZHK-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 131394-19-9
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | ClinicalTrials.gov (NCT01659580) Phase III Trial of Dantonic (T89) Capsule to Prevent and Treat Stable Angina. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.